"Photopheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.
| Descriptor ID |
D017893
|
| MeSH Number(s) |
E02.774.945.500.500 E04.292.762
|
| Concept/Terms |
Photopheresis- Photopheresis
- Extracorporeal Photopheresis
- Photopheresis, Extracorporeal
- Extracorporeal Photochemotherapy
- Extracorporeal Photochemotherapies
- Photochemotherapies, Extracorporeal
- Photochemotherapy, Extracorporeal
|
Below are MeSH descriptors whose meaning is more general than "Photopheresis".
Below are MeSH descriptors whose meaning is more specific than "Photopheresis".
This graph shows the total number of publications written about "Photopheresis" by people in this website by year, and whether "Photopheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photopheresis" by people in Profiles.
-
Variations in Therapeutic Plasma Exchange and Extracorporeal Photopheresis Practice Patterns: Survey Results From the ASFA Solid Organ Transplantation Subcommittee. J Clin Apher. 2026 Apr; 41(2):e70113.
-
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction. J Heart Lung Transplant. 2018 03; 37(3):340-348.
-
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial. Biol Blood Marrow Transplant. 2016 May; 22(5):862-8.
-
Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease. J Invest Dermatol. 2013 Aug; 133(8):2098-100.
-
Dendritic cells and cutaneous T-cell lymphomas. G Ital Dermatol Venereol. 2011 Apr; 146(2):103-13.
-
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood. 2008 Aug 15; 112(4):1515-21.
-
Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant. 2006 Aug; 38(4):265-73.
-
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Biol Blood Marrow Transplant. 2006 Jan; 12(1 Suppl 2):37-40.
-
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006 Apr 15; 107(8):3074-80.
-
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003 Mar; 31(6):459-65.